R Alvarez-Sala
Overview
Explore the profile of R Alvarez-Sala including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
108
Citations
197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Granda P, Villamanan E, Heinz S, Laorden D, Romero D, Anon J, et al.
J Investig Allergol Clin Immunol
. 2023 Jun;
34(1):60-61.
PMID: 37357596
No abstract available.
2.
Laorden D, Hernandez I, Dominguez-Ortega J, Romero D, Alvarez-Sala R, Quirce S
Eur Ann Allergy Clin Immunol
. 2023 Mar;
56(4):169-175.
PMID: 36927725
Mepolizumab, a monoclonal antibody that interacts with IL-5, was the first anti-IL-5 approved for uncontrolled severe eosinophilic asthma. In several randomised, placebo-controlled trials, treatment with mepolizumab has shown a significant...
3.
Villamanan E, Fernandez de Uzquiano E, Garcia E, Sobrino C, Del Pozo A, Carpio C, et al.
Rev Clin Esp (Barc)
. 2022 Oct;
223(1):1-9.
PMID: 36182538
Background And Objective: Available data support differences by gender in the leadership of clinical investigations (CI). This study analyzes to what extent women lead these investigations. Materials And Methods: Observational-retrospective...
4.
Villamanan E, Herrero A, Alvarez-Sala R, Quirce S
J Investig Allergol Clin Immunol
. 2020 Jan;
30(4):305-306.
PMID: 31983677
No abstract available.
5.
Prados C, Lerin M, Cabanillas J, Gomez-Carrera L, Alvarez-Sala R
Respir Med Case Rep
. 2017 Apr;
21:49-51.
PMID: 28393935
Background And Aims: To specify the prevalence of patients diagnosed with CF at age of ≥60 year-old and to analyze their characteristics. Patients And Methods: Observational study of CF patients...
6.
Villamanan E, Gonzalez D, Armada E, Ruano M, Alvarez-Sala R, Herrero A
Rev Calid Asist
. 2015 Nov;
31(2):99-105.
PMID: 26542789
The protection provided by patents on medicines has a limited duration. The expiry of patents expiration allows copies of the drugs to be released, competing with original. At first, they...
7.
Villamanan E, Ruano M, Larrubia Y, Baumann T, Armada E, Herrero A, et al.
Int J Clin Pharm
. 2014 Oct;
36(6):1099-100.
PMID: 25348680
No abstract available.
8.
Iglesias A, Artiles I, Cabanillas J, Alvarez-Sala R, Prados C
Case Rep Pulmonol
. 2014 Oct;
2014:192146.
PMID: 25295210
There are not many articles about the chronic bronchial infection/colonization in patients with underlying lung disease other than cystic fibrosis (CF), especially with non-CF bronchiectasis (NCFBQ). The prevalence of B....
9.
Lerin M, Prados C, Martinez M, Maiz L, Giron R, Sole A, et al.
Rev Clin Esp (Barc)
. 2014 Jun;
214(6):289-95.
PMID: 24948579
Aim: To know the prevalence of the patients diagnosed of cystic fibrosis (CF) older than 18 years old of five specific Spanish Units and to analyze their clinical, genetic and...
10.
Villamanan E, Larrubia Y, Ruano M, Moro M, Sierra A, Perez E, et al.
Rev Calid Asist
. 2013 Jun;
28(5):313-20.
PMID: 23731574
Objective: to evaluate health personnel perceptions about medical order entry systems concerning the effect on workflow, medication errors risk and assessment of its potential advantages. Material And Methods: A cross-section...